πŸ‡ΊπŸ‡Έ FDA
Patent

US 11110090

Aminopyrimidines as ALK inhibitors

granted A61KA61K31/506A61P

Quick answer

US patent 11110090 (Aminopyrimidines as ALK inhibitors) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/506, A61P, A61P35/00